Skip to content

13F-HR filed by First Light Asset Management, LLC

First Light Asset Management, LLC filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 52 holding rows worth $261,919,000.

Accession
0001387131-17-002774
Filed
2017-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2017

A holdings report, 52 entries on the cover page, a total value of $261,919,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $261,919,000 with VALUE read as thousands by filing date, 13F file number 028-16064. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NEOGENOMICS INC64049M209COM NEW2,653,654$20,937,000thousands by filing date
AKORN INC009728106COM775,591$18,676,000thousands by filing date
ATRICURE INC04963C209COM956,458$18,316,000thousands by filing date
IMMUNOMEDICS INC452907108COM2,096,495$13,564,000thousands by filing date
INTERSECT ENT INC46071F103COM667,504$11,448,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO55,791$9,721,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS622,238$9,638,000thousands by filing date
Enzo Biochem Inc294100102Common Stock1,121,736$9,389,000thousands by filing date
HARVARD BIOSCIENCE INC416906105COM3,204,485$8,332,000thousands by filing date
HEALTHSTREAM INC42222N103COM309,931$7,510,000thousands by filing date
TELIGENT INC NEW87960W104COM949,377$7,415,000thousands by filing date
LHC GROUP50187A107COM126,123$6,798,000thousands by filing date
MEDICINES CO584688105COM136,739$6,687,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM93,465$6,643,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW62,640$6,630,000thousands by filing date
VERACYTE INC COM92337F107Stock720,878$6,618,000thousands by filing date
ENTELLUS MED INC29363K105COM407,497$5,623,000thousands by filing date
K2M GROUP HLDGS INC48273J107COM271,698$5,573,000thousands by filing date
HERON THERAPEUTICS INC427746102COM363,689$5,455,000thousands by filing date
OMNICELL COM COM68213N109Stock133,823$5,440,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock414,611$5,373,000thousands by filing date
SPECTRANETICS CORP84760C107COM182,156$5,305,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM223,421$5,244,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock566,332$5,063,000thousands by filing date
AMEDISYS INC023436108COM92,549$4,728,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK170,007$4,561,000thousands by filing date
BLUEBIRD BIO INC09609G100COM49,270$4,479,000thousands by filing date
MODEL N INC607525102COM420,750$4,397,000thousands by filing date
BIO-TECHNE CORP09073M104COM38,202$3,883,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM31,592$2,773,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM23,125$2,529,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM114,755$2,280,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH7,097$2,082,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock50,189$2,018,000thousands by filing date
ALKERMES PLCG01767105SHS29,689$1,737,000thousands by filing date
CELGENE CORP151020104COM13,701$1,705,000thousands by filing date
QUIDEL CORP74838J101COM74,383$1,684,000thousands by filing date
STREAMLINE HEALTH SOLUTIONS86323X106COM1,635,945$1,669,000thousands by filing date
POWERSHARES ETF TR II S&P SMCP73937B886ETF - EQUITY17,285$1,383,000thousands by filing date
Health Care Select Sector SPDR Fund81369Y209SHS18,241$1,356,000thousands by filing date
TEARLAB CORP878193200COM421,025$1,196,000thousands by filing date
iShares U.S. Medical Devices ETF464288810SHS7,580$1,148,000thousands by filing date
MACROGENICS INC556099109COM61,503$1,144,000thousands by filing date
LEMAITRE VASCULAR INC525558201COM46,203$1,138,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH9,499$659,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR6,720$304,000thousands by filing date
CHEMBIO DIAGNOSTICS163572209COM55,452$294,000thousands by filing date
Pfizer Inc.717081103COM8,558$293,000thousands by filing date
Merck & Co.,Inc.58933Y105COM4,294$273,000thousands by filing date
Johnson & Johnson478160104COM2,183$272,000thousands by filing date
AbbVie,Inc.00287Y109COM4,159$271,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR3,572$265,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001387131-17-002774this filing2017-05-15acceptance time not in the bulk data set